Department of Gastroenterology, Asan Digestive Disease Research Institute, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea.
Gut Liver. 2018 May 15;12(3):246-254. doi: 10.5009/gnl17162.
BACKGROUND/AIMS: We aimed to investigate whether the current indications for curative endoscopic resection (ER) of gastric cancer (GC) can be applied to GC caused by adenoma. Additionally, we attempted to identify factors predictive of lesions subsequently found in addition to the expanded indications for ER.
We retrospectively analyzed 342 patients diagnosed with GC caused by adenoma who underwent ER at a single tertiary center between February 2011 and December 2014. The gross whole tumor size was measured using the endoscopically resected specimen. The microscopic whole tumor size was measured using mapping paper. The estimated cancer size was calculated using the microscopic whole tumor size and the square root of the carcinoma component.
A gross whole tumor size ≥3 cm, carcinoma component ≥35%, and gross ulceration were predictive of lesions other than the expanded indications for ER. The overall rate of lymph node metastasis was 0.3% (1/327), which only occurred in one patient with a lesion other than the expanded indications (4.5%, 1/22).
The current indications for curative ER in GC can be applied to GC caused by adenoma. In cases suspected of having lesions other than the expanded indications, patients should be cautiously selected for ER to reduce the risk of an inappropriate procedure.
背景/目的:我们旨在探讨当前用于治疗性内镜下切除(ER)胃癌(GC)的适应证是否可适用于腺瘤所致的 GC。此外,我们试图确定除 ER 扩大适应证外,预测存在附加病变的因素。
我们回顾性分析了 2011 年 2 月至 2014 年 12 月在一家三级中心接受 ER 治疗的 342 例腺瘤所致 GC 患者。使用内镜切除标本测量大体全肿瘤大小。使用描图纸测量显微镜下全肿瘤大小。使用显微镜下全肿瘤大小和癌成分的平方根计算估计的癌症大小。
大体全肿瘤大小≥3cm、癌成分≥35%和大体溃疡是除 ER 扩大适应证以外的病变的预测因素。淋巴结转移的总发生率为 0.3%(1/327),仅发生在一例具有除 ER 扩大适应证以外病变的患者中(4.5%,1/22)。
当前用于治疗性 ER 的 GC 适应证可适用于腺瘤所致的 GC。对于疑似存在除 ER 扩大适应证以外病变的患者,应谨慎选择 ER,以降低不适当手术的风险。